Isabel Hurtado
Overview
Explore the profile of Isabel Hurtado including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
440
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Johannes C, Ziemiecki R, Pladevall-Vila M, Ebert N, Kovesdy C, Thomsen R, et al.
Diabetes Ther
. 2024 Dec;
16(2):205-226.
PMID: 39688776
Introduction: The clinical landscape for the treatment of patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) is rapidly evolving. As part of the FOUNTAIN platform (NCT05526157; EUPAS48148),...
2.
Hurtado I, Robles C, Peiro S, Garcia-Sempere A, Llopis F, Sanchez F, et al.
RMD Open
. 2024 Sep;
10(3).
PMID: 39313306
Objective: Fibromyalgia syndrome (FMS) is characterised by widespread pain and is associated with mood disorders such as depression as well as poor sleep quality. These in turn have been linked...
3.
Pajouheshnia R, Gini R, Gutierrez L, Swertz M, Hyde E, Sturkenboom M, et al.
Pharmacoepidemiol Drug Saf
. 2024 Aug;
33(8):e5871.
PMID: 39145406
Purpose: Metadata for data dIscoverability aNd study rEplicability in obseRVAtional studies (MINERVA), a European Medicines Agency-funded project (EUPAS39322), defined a set of metadata to describe real-world data sources (RWDSs) and...
4.
Gini R, Pajouheshnia R, Gutierrez L, Swertz M, Hyde E, Sturkenboom M, et al.
Pharmacoepidemiol Drug Saf
. 2024 Aug;
33(8):e5884.
PMID: 39145403
No abstract available.
5.
Hurtado I, Robles C, Peiro S, Garcia-Sempere A, Sanfelix-Gimeno G
Diabetologia
. 2024 Aug;
67(11):2471-2480.
PMID: 39103719
Aims/hypothesis: Regulators worldwide are reviewing safety data on glucagon-like peptide-1 receptor agonists (GLP-1RA), following reports by the Icelandic Medicines Agency in July 2023 of suicidal ideation and self-injury (SIS) in...
6.
Martinez-Ibanez P, Marco-Moreno I, Garcia-Sempere A, Peiro S, Martinez-Ibanez L, Barreira-Franch I, et al.
JAMA Netw Open
. 2024 May;
7(5):e2410063.
PMID: 38728033
Importance: Patient empowerment through pharmacologic self-management is a common strategy for some chronic diseases such as diabetes, but it is rarely used for controlling blood pressure (BP). Several trials have...
7.
Gamon V, Hurtado I, Salazar-Fraile J, Sanfelix-Gimeno G
Sci Rep
. 2024 Mar;
14(1):5138.
PMID: 38429377
No abstract available.
8.
Del Pino-Sedeno T, Infante-Ventura D, Hernandez-Gonzalez D, Gonzalez-Hernandez Y, Gonzalez de Leon B, Rivero-Santana A, et al.
Front Pharmacol
. 2024 Feb;
15:1327155.
PMID: 38318137
Current evidence reveals concerning rates of non-adherence to antidepressant treatment, possibly influenced by various relevant determinants such as sociodemographic factors or those related to the health system and their professionals....
9.
Garcia-Sempere A, Hurtado I, Robles C, Llopis-Cardona F, Sanchez-Saez F, Rodriguez-Bernal C, et al.
BMJ Qual Saf
. 2023 Jul;
33(1):13-23.
PMID: 37414557
Objective: To identify individual and initial prescription-related factors associated with an increased risk for opioid-related misuse, poisoning and dependence (MPD) in patients with non-cancer pain. Methods: Cohort study linking several...
10.
Hurtado I, Robles C, Peiro S, Garcia-Sempere A, Llopis-Cardona F, Sanchez-Saez F, et al.
Front Pharmacol
. 2022 Dec;
13:1025340.
PMID: 36467078
Europe has seen a steady increase in the use of prescription opioids, especially in non-cancer indications. Epidemiological data on the patterns of use of opioids is required to optimize prescription....